<DOC>
	<DOCNO>NCT02052947</DOCNO>
	<brief_summary>One crucial challenge future Alzheimer 's disease ( AD ) therapeutic approach elderly target main pathological process responsible disability dependency . However , progressive cognitive impairment occur age 70 often relate mixed lesion neurodegenerative vascular origin . Whereas young patient mostly affected pure lesion , age favor occurrence co-lesions AD , vascular Lewy body type . Pure DLB ( Dementia Lewy Body ) AD distinct disorder often coexist old age patient , Abeta pathology DLB/AD case different observe patient AD alone . Vascular dementia ( VD ) AD cerebrovascular disease ( AD+CVD ) lead cause dementia next AD alone . Lack consensus persist diagnosis criterion VD AD+CVD , due part clinical , pathological heterogeneity multiple pathological subtypes . We know precise role weight brain lesion type disability progression elderly . To target actual pathological process , need disclose functional weight AD , Lewy body vascular lesion type elderly . Most study report functional clinical abnormality patient pure pathology . Thus , co-morbid process involve transition independent functional status disability elderly co-lesions still remain elucidated . Neuropathological examination often perform late stage answer question mild moderate stage . Brain MRI , Single Photon Emission Computed Tomography ( SPECT ) DaTscan® CSF biomarkers help routinely perform diagnosis pure mixed lesion responsible dementia . The topography atrophy MRI help provide information etiological diagnosis . Medial temporal lobe atrophy MRI good discriminatory power AD compare DLB VD pathologically confirm case . DaTscan® SPECT present good sensitivity specificity early stage DLB . The good diagnosis value CSF biological marker lead recently inclusion research diagnosis criterion AD . Low Aβ1-42 high level total tau hyperphosphorylated tau isoforms appear sensitive specific CSF biomarkers . Aβ1-42 lower AD , well neurodegenerative disease like DLB , VD . The combination MRI , particularly medial temporal atrophy measure vascular lesion FLAIR MRI sequence , SPECT CSF biomarkers seem incremental value diagnosis AD , VD , DLB mix profile . The aim study identify biomarkers ( MRI , SPECT-DaTscan® CSF ) , combination , predictive functional disability elderly present progressive cognitive decline relate AD , DLB , VD mix pattern .</brief_summary>
	<brief_title>Co-LEsions Alzheimer Disease Related Disorders</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<criteria>Male female subject age 70 year Outpatient consult one Memory Centres participate study Patients meet diagnosis criterion dementia due Alzheimer 's disease ( McKhann , Knopman et al . 2011 ) , vascular dementia ( NINCDSAIREN criterion , Roma´n , G. C. , Tatemichi , T. K. , Erkinjuntti , T. , et al . ( 1993 ) , Lewy body disease ( McKeith , Dickson et al . 2005 ) , patient present mixed sign symptom suggest combination diagnosis Mild moderate dementia stage ( MMSE criterion &gt; 15 ) Being affiliate health insurance Patient sufficient visual , auditory oral write French language skill complete clinical neuropsychological evaluation Accompanied close relation sufficient contact subject ass dependency Patients psychiatric disorder ( Axe 1 DSMIV ( Diagnostic Statistical Manual Mental Disorders ) disease ) except patient depressive anxious disorder stabilize 3 month Patients take neuroleptic psychotropic medication Patients take psychotropic medication , exception antidepressant , hypnotic , anxiolytic , acetylcholinesterase inhibitor memantine prescribe stabilised 3 month Patients sign symptom suggestive dementia relate disease AD , vascular Lewy disease , mixed form Patients neurological disease Patients progressive unstable pathology could interfere variable consideration Deafness blindness could compromise evaluation patient Patients able undergo DaTscan® : moderate severe hepatic renal impairment , know hypersensitivity ioflupane excipients Patient live institution Patient meeting brain MRI exclusion criterion ( pacemaker , aneurysm clip , artificial heart valve , ear implant , metal fragment foreign object eye , skin , body ) refuse MRI Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>cerebrovascular disease</keyword>
	<keyword>Lewy body disease</keyword>
	<keyword>MRI</keyword>
	<keyword>SPECT</keyword>
	<keyword>CSF</keyword>
	<keyword>biomarkers</keyword>
	<keyword>disability</keyword>
	<keyword>Multicenter prospective cohort study</keyword>
</DOC>